Wednesday 29 January 2020 ,
Wednesday 29 January 2020 ,
Latest News
  • China confirms 5,974 virus cases as death toll rises to 132
  • Candidates out to woo voters as electioneering ends today
  • Citizens miffed by loudspeaker use
  • 3 killed in Dinajpur road crash
  • DNCC to procure 42,450 streetlights
5 August, 2019 00:00 00 AM

Diabetic women more likely to have stillborn baby, study finds

BBC New Health
Diabetic women more likely to have stillborn baby, study finds

Diabetic women are more than four times more likely to have a stillborn baby than those without the condition, a new study has found.

Researchers from the University of Glasgow looked at the records of nearly 4,000 Scottish diabetic mothers.

They found high blood sugar levels in pregnant diabetics was a "risk factor" in stillbirths.

The Body Mass Index (BMI) of diabetic women is also a critical factor, the study found.

Researchers also found that a third of stillbirths in diabetic women happened at full term.

Earlier delivery

Dr Sharon Mackin, who carried out the study, said: "It is vital that we, as healthcare professionals, find better ways to support women during their fertile ages to optimise weight and blood sugar, so that when entering pregnancy, whether that be planned or unplanned, they are better prepared and their risk of adverse outcomes is reduced.

"It is important that women with diabetes are mindful of this, and are able to access appropriate pre-conceptual counselling, even if not imminently planning a pregnancy.

"Women with diabetes should also make contact with their diabetes clinic as soon as they get a positive pregnancy test so that we can see and support them early on."

The study ruled that earlier delivery may be considered "an attractive option" but that more research was needed before recommendations for optimal timing were made.

Dr Mackin said the question "has to be asked about whether earlier delivery of all diabetic pregnancies could prevent these term stillbirths".

She said: "We don't know the answer to this. The optimal timing of delivery in such pregnancies is not clear."

The study identified 5,392 babies born to 3,847 mothers with diabetes in Scotland between April 1998 to June 2016.

Mothers with type 1 diabetes were more than three times likely to deliver a stillborn child, while those with type 2 were at least four times likely.

Stillbirth rates were 16.1 per 1,000 births in the women with type 1 diabetes and 22.9 per 1,000 births in type 2 diabetes, compared with 4.9 per 1,000 births in the general population.

Women with type 1 who had stillbirths had higher than average blood sugar levels throughout their pregnancy, while pre-pregnancy levels were a more important predictor of stillbirth in those with type 2.

Babies with the highest and lowest birth weights were most at risk, the study published in the Diabetologia journal, found.

Dr Emily Burns, head of research communications at Diabetes UK, said: "Most women with diabetes have healthy pregnancies and healthy babies, but this research reinforces the importance of supporting women to manage their blood glucose levels if they are planning a pregnancy, in order to reduce their risk of complications as much as possible.

"It also suggests that losing extra weight, for women with type 2 diabetes who are overweight, could help to reduce this risk as well.

"We need research to find better ways of predicting who is most at risk of complications during pregnancy, to ensure support can be provided to those who need it most."

 

Comments

Most Viewed
Digital Edition
More story
Editor Speaks

Editor Speaks

Leprosy or Hensen’s Disease is an infectious, chronic granulomatus disease caused by an acid and alcohol fast bacillus called Micobacterium Leprae.…
Q&A on Leprosy

Q&A on Leprosy

What is leprosy? Leprosy is a chronic, progressive bacterial infection caused by the bacterium Mycobacterium leprae. It primarily affects the nerves of…
Leprosy elimination

Leprosy elimination

Leprosy is a chronic infectious disease caused by Mycobacterium leprae, an acid-fast, rod-shaped bacillus. The disease mainly affects the skin, the peripheral…
Global Leprosy Strategy 2016-2020

Global Leprosy Strategy 2016-2020

The past three decades have witnessed some impressive advances in leprosy control. Elimination as a public health problem (i.e. registered prevalence…
Sepsis: Everything you need to know

Sepsis: Everything you need to know

Sepsis is a life-threatening illness caused by body's response to an infection. This infection injures its own tissues and organs, potentially leading…
Mystery virus in Wuhan identified as novel coronavirus

Mystery virus in Wuhan identified as novel coronavirus

Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause…
Belly fat linked with repeat heart attacks

Belly fat linked with repeat heart attacks

Heart attack survivors who carry excess fat around their waist are at increased risk of another heart attack, according to research published today in…
5 Things to do after your child is diagnosed with autism

5 Things to do after your child is diagnosed with autism

KACIE After my daughter was diagnosed with autism, I learned five important lessons I want to pass on to other families. There is a lot more to this list…
BAUS Conf 2020

BAUS Conf 2020

14th  BAUS Conference 2020 of Bangladesh Association of Bangladesh Association of Urological Surgeons was held at Intercontinental Hotel, Dhaka on…
'Alarming' one in five deaths due to sepsis

'Alarming' one in five deaths due to sepsis

JAMES GALLAGHER   One in five deaths around the world is caused by sepsis, also known as blood poisoning, shows the most comprehensive analysis of…
FDA warns of surgical gowns that may not be sterile

FDA warns of surgical gowns that may not be sterile

Certain surgical gowns and surgical packs made by Cardinal Health may not be sterile and should not be used, the U.S. Food and Drug Administration said…
FDA approves Ozempic (semaglutide) for cardiovascular risk reduction in adults with Type 2 Diabetes and known heart disease

FDA approves Ozempic (semaglutide) for cardiovascular risk reduction in adults with Type 2 Diabetes and known heart disease

Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Ozempic (semaglutide) injection 0.5 mg…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting